Ask question
Ask question
×
Emoxipin



Emoxipin

Solution for injections 10 mg/ml

INN: Methylethylpiridinol

Registration number: R N001173/01

Pharmacotherapeutic group: Antioxidant

Indications for use:

Subconjunctival and intraocular hemorrhage of various origins;

Angioretinopathia (including diabetic retinopathy);

Central and peripheral chorioretinal dystrophy;

Thrombosis of the central retinal vein and its branches;

Myopia complications;

Angiosclerotic macular degeneration (dry form);

Eye surgeries; conditions after surgery for glaucoma with choroidal detachment;

Degenerative diseases of the cornea;

Corneal injuries, inflammation and burns;

Protection of the cornea (while wearing contact lenses) and the retina of the eye from exposure to high-intensity light (laser and sun burns, during laser coagulation).

Presentation:

Solution for injections 10 mg/ml, 1 ml in ampules. 5 ampules in blister packaging from PVC film and aluminum foil or without foil.

1 or 2 blister packs (with or without foil) with instructions for use of the medication in carton packaging.



Leave a comment